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Compensatory growth and regeneration of skeletal muscle is de-
pendent on the resident stem cell population, satellite cells (SCs).
Self-renewal and maintenance of the SC niche is coordinated by the
paired-box transcription factor Pax7, and yet continued expression
of this protein inhibits the myoblast differentiation program. As
such, the reduction or removal of Pax7 may denote a key prerequi-
site for SCs to abandon self-renewal and acquire differentiation
competence. Here, we identify caspase 3 cleavage inactivation of
Pax7 as a crucial step for terminating the self-renewal process. In-
hibition of caspase 3 results in elevated Pax7 protein and SC self-
renewal, whereas caspase activation leads to Pax7 cleavage and
initiation of the myogenic differentiation program. Moreover, in
vivo inhibition of caspase 3 activity leads to a profound disruption
in skeletal muscle regeneration with an accumulation of SCs within
the niche. We have also noted that casein kinase 2 (CK2)-directed
phosphorylation of Pax7 attenuates caspase-directed cleavage. To-
gether, these results demonstrate that SC fate is dependent on
opposing posttranslational modifications of the Pax7 protein.
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Postnatal skeletal muscle retains a robust capacity for com-pensatory growth and regeneration in response to injury and
disease. This physiologic adaptation of skeletal muscle is largely
dependent on a resident stem cell population, termed satellite
cells (SCs), which exist in a well-defined position juxtaposed to
the myofiber (1, 2). In resting skeletal muscle, SCs have low
homeostatic turnover and are maintained in a nonproliferative,
quiescent state (3). Exogenous activation of SCs may lead to a
process of self-renewal, which maintains the stem cell niche, or
these cells may commit to the myogenic differentiation program,
fusing with existing myofibers to accomplish muscle growth and
repair (4, 5). The factors that direct an activated SC to self-renew
versus initiate myogenesis are not fully defined, and yet a rea-
sonable hypothesis would envision that acquisition of these di-
vergent cell fates requires a mutually exclusive molecular milieu.
The establishment of the SC lineage is controlled by expression
of Pax7, a paired-box transcription factor (6). Targeted deletion of
Pax7 results in an almost complete loss of SCs, with a striking
deficit in muscle regenerative capacity (6, 7). Although Pax7 is
required to instruct the myogenic fate of SCs, continued expression
of this protein inhibits the myoblast differentiation program (8, 9).
Pax7 has also been reported to regulate distinct panels of genes
that promote proliferation and antagonize myogenic differentia-
tion, a function that is consistent with a SC-enriched function for
this transcription factor (10). As such, the reduction or removal of
Pax7 may denote a key prerequisite for SCs to abandon self-
renewal and acquire differentiation competence. How the activated
SC retains or eliminates Pax7 protein activity remains unknown.
A probable mechanism that may influence Pax7 protein activity
(and by extension SC fate choice) is the restricted deployment of
directed proteolysis. The caspase 3 protease, originally identified as
the central effector of multiple cell death pathways, has been
demonstrated to control cell fate determination independent of
inducing cell death (11). Transient activation of caspase 3 is essential
for inducing the differentiation program across a broad range of
lineage restricted progenitor cells (12). In addition, caspase 3 has
been observed to limit self-renewal of embryonic stem cells through
direct proteolysis and inactivation of the key pluripotency factor
Nanog (13). In skeletal muscle myoblasts, caspase 3 directs a dif-
ferentiation specific gene expression program by activating the cas-
pase-responsive DNase CAD. Once active, CAD reprograms the
genome through targeted DNA damage/strand break events (14).
Previous observations have suggested Pax7 is subjected to cas-
pase/proteasome-dependent regulation (15). Here, we provide evi-
dence that Pax7 is a direct target of caspase 3 at aspartic acid
residues D187 and D208. Furthermore, we examined whether lim-
itation of SC self-renewal was dependent on caspase 3-targeted
cleavage of Pax7. We noted that loss or inhibition of caspase 3 ac-
tivity leads to the accumulation of Pax7 protein, expansion of the
SC self-renewing compartment, and impeded muscle regeneration.
Conversely, small molecule stimulation of caspase 3 depletes Pax7
protein and results in a down-regulation of Pax7 target genes.
Moreover, the ability of caspase 3 to target Pax7 is subject to an
additional regulatory control via CK2. Here, quiescent and self-
renewing SCs maintain elevated CK2 activity, which phosphorylates
Pax7 and prevents caspase-mediated degradation of Pax7. Together,
these results demonstrate that caspase cleavage of Pax7 is an early
and essential step to limit SC self-renewal, thereby establishing a
cellular environment that is permissive for muscle differentiation.
Results and Discussion
Inhibition of Caspase 3 Promotes Satellite Cell Self-Renewal. To ad-
dress the role of caspase 3 activity in SC function, we isolated single
muscle fibers from juvenile mice and performed immunofluorescence
Significance
Satellite cells form the resident stem cell population in adult
skeletal muscle, providing the foundation for postnatal growth
and repair of this tissue. Satellite cell self-renewal is main-
tained by the paired-box transcription factor Pax7, suggesting
that this protein is a key determinant in managing cell fate
decisions for this niche. Here, we show activation of caspase 3
protease limits satellite cell self-renewal, through targeted
cleavage and inactivation of Pax7 in a casein kinase (CK2)-
dependent manner. Temporal regulation of caspase 3 activity
may offer a robust mechanism to control the satellite cell
compartment and enhance skeletal muscle regeneration.
Author contributions: S.A.D., Y.K., D.W.L., M.A.R., and L.A.M. designed research; S.A.D.,
N.C.C., N.A.D., R.A.V.B., and Y.K. performed research; D.W.L. and M.A.R. contributed new
reagents/analytic tools; S.A.D., R.A.V.B., C.P., and L.A.M. analyzed data; and S.A.D. and
L.A.M. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
1To whom correspondence should be addressed. Email: lmegeney@ohri.ca.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1512869112/-/DCSupplemental.






















for active-caspase 3. Isolated and cultured myofibers provide an
amenable model that accurately reconstructs the transition of
SCs from quiescence to activation/early cell divisions, with well-
defined temporal kinetics (T = 0 postculture, quiescence; T = 48 h,
early activation; and T = 72 h, full activation) (9). No caspase 3
activity was observed immediately following fiber isolation; how-
ever, we observed focal caspase 3 activity in both early and late
activated SCs (Fig. 1A). This temporal activity pattern is reminis-
cent of caspase 3 activation in other nondeath settings, which in-
clude differentiation of committed skeletal myoblasts and stem
cells from a variety of lineages, including neuronal and hemato-
poietic progenitors (12, 13, 16, 17).
To examine the function of caspase 3 in SC activation and self-
renewal, isolated myofibers were incubated with a cell permeable
caspase 3 specific peptide inhibitor (20 μM z.DEVD.fmk) and
assessed for markers of self-renewal (Pax7) versus commitment
to differentiation (MyoD). Sustained Pax7 expression in the
absence of myogenic markers is indicative of the self-renewing
population (8). Alternatively, SCs with down-regulation of Pax7
and up-regulation of the transcription factors MyoD and myo-
genin are considered to be a cell population committed to differ-
entiation. SCs expressing both Pax7 and MyoD are understood to
be committed cells that remain in a proliferative state. Inactiva-
tion of caspase 3 resulted in a significant increase in the number of
Pax7+/MyoD− SCs on fibers at 3 d postisolation (34.85 ± 3.13%
DEVD vs. 15.74 ± 4.61% DMSO; P < 0.05) with a corresponding
decrease in the number of differentiating cells (Pax7−/MyoD+;
36.71 ± 3.79% DEVD vs. 54.67 ± 3.85% DMSO; Fig. 1 B and C).
The number of SCs undergoing self-renewal was only found to be
significantly increased at 3 and 4 d (38.69 ± 3.77%DEVD vs. 21.93±
2.69% DMSO) postisolation (Fig. 1D). We saw no significant dif-
ference in the number of SCs undergoing self-renewal at 2 d
postisolation (Fig. 1D), suggesting caspases affect SC fate after
the initial division occurs. To confirm this, we used the Myf5-
Cre/Rosa-YFP lineage-tracing mouse, which irreversibly labels
SCs that have at one time expressed the myogenic transcription
factor Myf5. This strategy has been used to identify a population
of SCs that are YFP-negative and can undergo a symmetric
(producing two YFP- cells) or asymmetric division (producing
one YFP− and one YFP+ cell) (4). We observed no significant
change in these two populations on fibers treated with the cas-
pase 3 inhibitor; however, we did see a decrease in the number of
differentiating SCs (YFP+/MyoD−; 5.30 ± 1.55% in DEVD vs.
12.78 ± 3.44% DMSO) (Fig. S1 A and B). Importantly, the total
number of SCs per fiber did not change with or without caspase 3
inhibition at any of the time points examined (Fig. 1D and Fig.
S1B), confirming that caspase activation in the activated SC
population impacts the self-renewal process post Myf5 induction,
rather than influencing cell death/cell survival per se.
Caspase 3 Activity Is Required for Skeletal Muscle Regeneration.
Muscle regeneration requires proper activation, proliferation,
and differentiation of SCs to restore muscle function (18). To
determine whether caspase 3 is important to this process, we
injected the tibialis anterior (TA) muscle with an adenovirus
containing a p35-IRES-GFP vector (or GFP alone as a control).
The baculovirus p35 protein is a potent biologic inhibitor of
caspase 3/7 activity, which we have previously used for in vivo
characterization of caspase activity in the heart (19). Infection
with the p35-containing virus (Adp35) at 2 d post-cardiotoxin
(CTX) injury resulted in a significant reduction in the minimal
Feret’s diameter (with the majority of fibers measuring between
10–20 μm; 30.03 ± 2.27%) compared with control (AdGFP)-
treated muscle (17.33 ± 4.52% of fibers between 10–20 μm) at
14 d postinjury (Fig. 1E and Fig. S1C). This was accompanied by a
dramatic increase in the number of SCs in the niche (4.49 ± 0.37
GFP+ cells/field Adp35 vs. 1.7 ± 0.26 GFP+ cells/field AdGFP;
Fig. 1 F and G), disorganized muscle ultrastructure, and in-
effective repair (Fig. S1D). In addition, we also examined protein
content in TA muscles at 3 and 7 d postinjury to assess the Pax7
protein levels as a proxy for monitoring the SC self-renewal re-
sponse. We noted a robust increase in Pax7 protein in Adp35-
infected muscle at day 7 compared with uninjured control, with a
consistent increase in Pax7 protein in the Adp35-treated muscle
compared with AdGFP control muscles at day 7 (Fig. 1 H and I).
Taken together with the isolated myofiber experiments, these
observations are consistent with the hypothesis that caspase 3
activity may act as a critical step in the regulation of SC-medi-
ated skeletal muscle repair. At this juncture, it is salient to
consider that the in vivo experimental approach (Adp35 in-
fection) may also result in the loss of caspase 3 activity in
transduced non-muscle cell types, a condition that could sepa-
rately influence the outcome of the regenerative process. For
example, caspase 3 activity is an essential requirement for both
macrophage and T-cell maturation/differentiation (12), and these
immune cell types have been demonstrated to infiltrate damaged
muscle tissue and enhance regeneration (20). Therefore, the
impaired regeneration that follows Adp35 infection may derive
from a loss of caspase function in both SCs and critical immune
cell subtypes. As such, it will be of considerable interest to parse
caspase 3 function within each tissue compartment and de-
termine the relative contribution of each protease signal to the
overall repair process.
Pax7 Protein Is Degraded via Caspase 3-Directed Cleavage. The in-
creased numbers of self-renewing SCs following caspase 3 in-
hibition is consistent with the premise that this protease may act
to cleave and inactivate the factor(s) that govern the self-renewal
process. Pax7 is a logical target in this regard, because (i) the
protein content has been shown to decline faster than message
content in differentiating myoblasts (21); and (ii) simple in-
spection of the Pax7 protein reveals conserved caspase 3 cleav-
age sites (Fig. S2A). To address a prospective posttranslational
regulation of Pax7, we used primary derived myoblasts as a
reliable proxy for SCs (which can be harvested in sufficient
quantity to conduct accurate biochemical analysis) (22). Pax7
protein is rapidly lost following low serum induction of differ-
entiation, and yet peptide inhibition of caspase 3 maintains el-
evated Pax7 protein for a 24 h period (Fig. 2A). To determine
whether caspase 3 directly targets the Pax7 protein, we con-
ducted an in vitro cleavage assay using recombinant active-
caspase 3 and recombinant Pax7 proteins. Addition of active-
caspase 3 was sufficient to induce an immune-reactive Pax7
cleavage product of ∼40 kDa (ΔPax7; Fig. 2B). This cleavage
event was blocked by addition of the caspase 3 peptide inhibitor,
confirming the specificity of Pax7 as a caspase 3 substrate.
Next, we sought to identify the caspase 3 cleavage site(s)
within Pax7 and whether the cleavage event is consistent with
producing a loss of function for Pax7. Importantly, we observed
both a 40-kDa band on a silver-stained gel, which corresponded
to the immune-reactive fragment identified via Western blot
analysis, as well as a 20-kDa fragment, as predicted, upon ad-
dition of active-caspase 3 (Fig. 2C, arrows). These two bands
were excised and processed for liquid chromatography-tandem
mass spectrometry (LC-MS/MS), identifying peptides that clus-
tered to either the N terminus (and within the paired domain) in
the case of the 20-kDa fragment or the C terminus (including the
homeodomain) for the 40-kDa fragment (Fig. S2B). This analysis
suggested a physiologic cleavage event that parsed these two re-
gions. To identify the precise caspase 3 cleavage site (an exposed
C-terminal aspartic acid), we subjected aliquots of the whole
cleavage reaction to enzymatic digestion using three different
endoproteases (Chymotrypsin, Trypsin, GluC). Analysis of the
Pax7 cleavage reaction products revealed a number of peptides
produced following cleavage at D187 that could not be attributed
to cleavage via the selected diagnostic endoproteases (Table S1).
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Fig. 1. Caspase 3 activity is required during early satellite cell fate decisions. (A) Fibers were stained for cleaved-caspase 3 (green), Pax7 (red), and DAPI
(blue) at 48 and 72 h following isolation. Active caspase 3 was observed at a low frequency in fiber-associated SCs at 48 and 72 h but not at time 0 in
quiescent SCs. (B) Fibers were cultured in z.DEVD.fmk (DEVD; 20 μM) (Right) or DMSO (control) (Left) for 3 d and stained for Pax7 (red), MyoD (green),
and DAPI (blue). (Scale bars: 10 μm.) (C ) Quantification of the number of SCs expressing each marker at 3 d postinjury (P.I.) expressed as a percentage of
the total number of SCs (>30 fibers per treatment per mouse; n = 4 mice). (D) Quantification of the number of self-renewing SCs (Pax7+/MyoD−) at 2, 3,
and 4 d postinjury (Left) and the total number of SCs per fiber (>30 fibers per treatment per time point per mouse; n = 4 mice) (Right). The percentage
of SCs undergoing self-renewal was significantly increase in DEVD-treated fibers compared with control at 3 and 4 d postinjury (*P < 0.05). (E ) Mouse TA
muscle was injured with CTX and injected with AdGFP or Adp35 at 2 d postinjury. TAs were embedded and 10-μm-thick frozen sections were stained for
immunofluorescence (IF) analysis (Fig. S1C), the minimal fiber Feret’s diameter was calculated for GFP+ fibers, and the frequency of fibers in each bin
size was expressed as a percentage of total number of fibers counted (>100 fibers/mouse; n = 3 mice/condition; *P < 0.05 AdGFP vs. Adp35).
(F ) Representative IF of muscle sections stained for GFP (green), Syn4 (red), laminin (white), and DAPI (blue). (Scale bars: 100 μm.) (G) The number of
GFP+/Syn4+ SCs were counted per field indicating an increase in the number of infected SCs in Adp35 infected muscle compared with AdGFP control
(*P < 0.05; n = 3). (H) Western blot of whole TA lysate isolated from 3 and 7 d regenerating muscle injected with AdGFP or Adp35 at 1 d postinjury.
(I) Densitometry results were quantitated from the Western blot (G) and averaged from three separate experiments. Pax7 levels were only found
significantly increased in day 7 Adp35 mice compared with uninjured control (ANOVA, P < 0.05). Error bars ± SEM.






















D187 mapped to a region that was not detected in either the
40-kDa or the 20-kDa fragments and was localized between the
paired and the homeodomain in which the respective peptides
clustered (Fig. S2B, underlined).
Interestingly, a recombinant Pax7 protein with an alanine
substitution at D187 (D187A) displayed partial cleavage via
caspase 3, suggesting that Pax7 contained additional cleavage
site(s) (Fig. S2C). Examination of the Pax7 amino acid sequence
indicated two additional aspartic acid residues (D202 and D208)
that retain prototypical caspase 3 recognition sites (23). To test
the caspase targeting of these residues, we generated the single
aspartic acid to alanine Pax7 mutations (D202A and D208A), as
well as the relevant Pax7 double mutants (D187A/D202A and
D187A/D208A) for use in the caspase cleavage assay. Recombi-
nant Pax7 containing the D187A/D202A double mutant, or any of
the single mutants, did not provide effective blockade of caspase
directed cleavage (Fig. 2D and Fig. S2C). However, Pax7 protein
containing the dual D187A/D208A aspartic acid to alanine mu-
tations was completely protected from caspase 3 cleavage (Fig.
2D), establishing these aspartic acids as de facto caspase target
sites. Finally, we examined whether caspase cleavage of Pax7
resulted in loss of function for the resulting Pax7 fragments. COS
cells were cotransfected with either full-length [Pax7 (FL)] or
truncated Pax7 constructs and a Pax7-responsive promoter linked
to a luciferase reporter (Myf5-57.5). COS cells transfected with
Pax7 (FL) induced expression of theMyf5-linked reporter, whereas
COS cells expressing either caspase-generated Pax7 fragment
[amino acids 1–208 (N terminus) or 209–503 (C terminus)] did not
activate the reporter (Fig. 2E). These results suggest that caspase
cleavage of Pax7 results in the generation of nonfunctional Pax7
fragments.
Exogenous Activation of Caspase 3 Results in Loss of Pax7 and SC
Differentiation. The combination of caspase inhibitor experi-
ments and in vitro cleavage assays indicate that caspase activity is
necessary to inactivate Pax7 and limit SC self-renewal. To de-
termine whether caspase 3 activation is a dominant (sufficient)
signal in determining SC fate, we used a specific small molecule
activator of caspase 3, termed procaspase 3-activating compound
1 (PAC-1), to engage protease activity. PAC-1 is a potent and
specific procaspase 3-targeted molecule that chelates the in-
hibitory zinc ions from the catalytic site of the enzyme, leading to
autoactivation (24). We have successfully used PAC-1 to pro-
duce nonlethal levels of caspase 3 activation, confirming a role
for this protease in the induction of cardiac hypertrophy (19).
Isolated myofibers treated for 3 h with PAC-1 (50 μM) displayed
a significant increase in the number of differentiating SCs (56.41 ±
1.00% Pax7−/Myogenin+) compared with control (40.81 ±
1.39%), suggesting caspase activation is sufficient to induce dif-
ferentiation of SCs (Fig. 3 A and B). We also noted PAC-1
treatment caused a reduction in the number of Pax7 positive cells
compared with control treated myofibers (Pax7+/syndecan4+
cells; Fig. S3 A and B). To independently confirm these obser-
vations, we also tested the capacity of PAC-1 to alter Pax7 levels
and the commitment of FACS isolated SCs. Western blot anal-
ysis revealed that SCs treated with 25 or 50 μM PAC-1 (a non-
lethal concentration in myoblast cultures; Fig. S3C) displayed a
dramatic reduction in Pax7 protein in growth media conditions, a
loss that was comparable to cells exposed to low serum induction
of differentiation (Fig. 3 C and D). Moreover, the PAC-1–
induced loss of Pax7 was concurrent to a reduction in the ex-
pression of the Pax7 target gene, Myf5 (Fig. 3E). Collectively,
these results support the hypothesis that caspase 3 is necessary
and sufficient to limit SC self-renewal and establish the molec-
ular conditions that are conducive for differentiation.
Phosphorylation of Pax7 via CK2 Prevents Caspase 3 Cleavage and
Promotes SC Self-Renewal. The standalone capacity of caspase 3 to
alter self-renewal implies that the SC may have evolved or co-
opted a mechanism(s) to restrain the protease targeting of Pax7.
Interestingly, casein kinase 2 (CK2) has been shown to produce a
steric inhibition on caspase 3 cleavage events via phosphorylation
of serine residues that reside in close proximity to the caspase 3
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Fig. 2. Pax7 protein is cleaved by caspase 3 at a cryptic cleavage site. (A) Differentiation time course of primary myoblasts treated with the caspase 3 peptide
inhibitor z.DEVD.fmk (20 μM) or DMSO control. Lysates were probed for αPax7 (upper blots) and α-alpha-tubulin (lower blots; loading control).
(B) Recombinant Pax7 protein and recombinant active caspase 3 were incubated for 3 h in standard cleavage assay conditions containing either DMSO or z.DEVD.
fmk (20 μM) as indicated. Reactions were then subjected to SDS/PAGE and Western blot analysis using αPax7 indicating a caspase 3-specific cleavage event
(ΔPax7). (C) Pax7 was subjected to caspase 3 cleavage as in B, followed by SDS/PAGE and silver stained using silver nitrate. Arrows indicate the Pax7 cleavage
fragments (corresponding to ∼40 and ∼20 kDa). (D) Recombinant Pax7 protein containing aspartic acid to alanine point mutations at site D187 and D202 or
D187 and D208 were subjected to caspase 3 cleavage, followed by Western blot analysis. Pax7 containing D187A/D202A was cleaved; however, D187A/D208A
was completely blocked compared with wild type. (E) Luciferase Assay performed in COS cells cotransfected with a Pax7 containing plasmid and a luciferase
reporter plasmid containing the Myf5 promoter. Error bars ± SEM; n = 3.



































established that caspase 3 cleavage sites and CK2 phosphorylation
sites strongly overlap (25, 26). Here, we show that the constitu-
tively active CK2 is present in all activated SCs and the majority
(73.0 ± 3.5%) of quiescent SCs (Fig. 4A). To address the physi-
ological relevance of CK2 activity and whether this kinase mod-
ulates SC self-renewal, we tested the effect of the CK2 specific
inhibitor tetrabromobenzotriazole (TBBt) on single fiber cultures.
We observed an increase in the differentiation potential of SCs
when treated with TBBt (33.55 ± 4.89%) compared with vehicle
control (DMSO; 23.68 ± 5.44%), as indicated by the increase in
Pax7−/MyoD+ SCs at 3 d postisolation (Fig. 4 B and C). There was
no significant difference in the number of SCs per fiber, indicating
that inhibition of CK2 activity does not impair cell survival.
The Pax7 amino acid sequence contains two serine residues
(S201 and S205), which are consistent with a CK2 consensus
sequence and in close proximity to the caspase-targeted aspartic
acid residue at position D208 (Fig. 4D). To confirm Pax7 is a
direct target of CK2, we performed an in vitro kinase assay (Fig.
4E), observing phosphorylation of Pax7 protein that was com-
pletely blocked by addition of the CK2 inhibitor TBBt (Fig.
S4A). Point mutations of Pax7 at S201 or S205 revealed that only
S201 in recombinant Pax7 protein was directly phosphorylated by
CK2 in vitro (Fig. 4F). The specificity of this phosphorylation
event was confirmed via MS peptide mapping of Pax7 protein
following incubation with CK2 (Fig. S4B).
Next, we tested whether prior CK2 phosphorylation of
recombinant Pax7 was sufficient to inhibit cleavage via active cas-
pase 3. Interestingly, CK2 phosphorylation of Pax7 resulted in the
generation of a single cleavage fragment of wild-type Pax7 (Fig.
4G, †), compared with the two cleavage products generated from
unphosphorylated Pax7 protein (Fig. 4G, † and ‡). This result
suggested that CK2 mediated phosphorylation of Pax7 S201 may
shield only one of the caspase-directed cleavage sites. To identify
the CK2 protected caspase cleavage site, we tested the D187A and
D208A single Pax7 mutants in the same serial kinase/cleavage as-
say used above. CK2 phosphorylation followed by caspase 3 in-
cubation of the D187A mutant displayed a similar cleavage pattern
to uncleaved Pax7 (Fig. 4G), whereas the caspase cleavage prod-
ucts generated from the D208A mutant were unaffected by a prior
CK2-mediated phosphorylation event (Fig. 4G, Center). This ex-
periment revealed that CK2 phosphorylation at S201 was sufficient
to block Pax7 cleavage at a single cleavage site, D208. Together
these results demonstrate a physiologic interaction between CK2
and caspase 3 in the control of Pax7 protein stability.
The persistence of CK2 in cells throughout differentiation is
related to the cell survival functions attributed to this kinase (27).
Moreover, the CK2 holoenzyme is constitutively active (28),
suggesting that the subcellular localization and binding partners
of CK2 are the primary determining factor in its substrate-
targeting capacity. To investigate the functional interplay between
Pax7 and CK2, we performed proximity ligation assay (PLA) on
primary myoblasts during a differentiation time course. We ob-
served strong CK2:Pax7 interactions in a perinuclear position
during growth (1.85 ± 0.13 puncta/cell) and at 6 h postdif-
ferentiation (1.51 ± 0.14 puncta/cell), which was rapidly dissi-
pated as the differentiation program proceeded (0.68 ± 0.10
puncta/cell by 24 h postdifferentiation) (Fig. 4H). The temporal















































































Fig. 3. Small molecule (PAC-1) activation of caspase 3 induces cleavage of Pax7 and loss of SC self-renewal. (A) Single fibers were treated with either 50 μM
PAC-1 or DMSO 60 h postisolation for 3 h, washed with fresh fiber media, and left for an additional 9 h. At 72 h postisolation, fibers were fixed and stained for
Pax7 (red), Myogenin (green), and DAPI (blue). (Scale bars: 20 μm.) (B) The number of SCs expressing each marker was counted and the number of myogenin
positive SCs (Pax7−/Myogenin+) was expressed as a percentage of total number of SCs (>30 fibers per treatment per mouse; n = 3 mice; *P < 0.05). (C) Western
blot analysis of primary myoblasts treated with PAC-1 at the indicated concentrations for 24 h or differentiation media (Diff). Lysates were probed with αPax7,
αCleaved-Caspase3, and αTubulin. (D) Densitometry analysis of Pax7 protein levels normalized to tubulin (loading control) shows a decrease similar to that
seen in differentiation conditions (n = 3). (E) Primary myoblasts treated with 25 μM or 50 μM PAC-1, DMSO (control) or differentiation media (diff) for 24 h.
RT-quantitative PCR (RT-qPCR) analysis using primers toMyf5 show a decrease inMyf5 expression in all treatment groups compared with DMSO control (n = 3;
*P < 0.05; **P < 0.005). Error bars ± SEM.
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Fig. 4. CK2 phosphorylates Pax7 and restricts SC differentiation. (A) Fibers were stained for CK2α (green), Pax7 (red), and DAPI (blue) (Left). CK2 is expressed
by fiber associated SCs at all time points tested (n = 3) (Right). (B) Fibers were cultured in the presence of the CK2 inhibitor TBBt (50 μM) or DMSO for 3 d and
stained for Pax7 (red), MyoD (green), and DAPI (blue). (C) Quantification of the number of SCs expressing each marker expressed as a percentage of total SCs.
Fibers treated with TBBt contained more differentiating Pax7−/MyoD+ SCs compared with DMSO control (n = 4; *P < 0.05). (D) Schematic of Pax7 protein
indicating the caspase 3 cleavage sites, as well as the CK2 phosphorylation site located between the paired domain (PD) and the homeodomain (HD) of Pax7.
The octapeptide (OP) sequence is bolded. (E) In vitro kinase assay of CK2 and Pax7. Autoradiography indicates Pax7 is phosphorylated by CK2 in a dose-
dependent manner. (F) In vitro kinase assay of wild-type Pax7 or Pax7 with site mutations at S201A or S205A. Autoradiography indicating loss of phos-
phorylation in the S201A mutant only. (G) Recombinant Pax7 was subjected to an in vitro kinase assay as in E. Aliquots from each reaction were then subjected
to caspase 3 cleavage, SDS/PAGE, and Western blot analysis using αPax7. Production of the Pax7 cleavage fragments (ΔPax7, † and ‡) was impaired in the
D187A mutant following preincubation with CK2. (H, Left) Primary myoblasts were fixed at the indicated times and stained for Pax7 (red) (Top), CK2 (green)
(Middle), or PLA [red dots indicate PLA reaction, costained with DAPI (blue)] (Bottom). (H, Right) PLA showed a positive interaction between CK2 and Pax7 at
growth and 6 h following differentiation (6 h Diff). The number of PLA-positive puncta per cell was quantified (80–150 cells/treatment; n = 3). Error bars
represent ± SEM. *P < 0.05. (Scale bars: 10 μm.)



































endogenous caspase 3 activation profile (29) and the consequent
loss of Pax7 protein. Additionally, we performed PLA on iso-
lated single fibers to verify the CK2 and Pax7 interaction in SCs
in situ. We detected a clear PLA signal in SCs at 48 h following
myofiber isolation, a time point that coincides with SC activa-
tion/proliferation and before the initiation of the differentiation
program (Fig. S4C). These results in combination with the re-
sults obtained using the CK2 inhibitor TBBt (Fig. 4 B and C)
suggest that CK2 ensures protein stability of Pax7 in pro-
liferating/self-renewing SCs and loss of this kinase function is a
key step in initiating myogenic differentiation.
Caspase 3 activation is an essential cue for promoting differ-
entiation of committed progenitor cells (12). Our study dem-
onstrates that caspase 3 also acts at a much earlier step in the life
cycle of muscle stem cells, by limiting the self-renewal process.
Caspase 3 blocks SC self-renewal by cleavage inactivation of
Pax7 protein, a mechanism that is counter balanced by CK2-
mediated phosphorylation of Pax7. Blockade of caspase activity
extends self-renewal in the SC pool, whereas inhibition of CK2
leads to increased numbers of differentiation committed cells,
revealing that SC fate is strongly influenced by competing post-
translational modifications of Pax7.
The mechanisms involved in the posttranslational regulation of
Pax7 protein stability during myoblast differentiation has only been
briefly analyzed (15). However, its close paralogue, Pax3, has been
demonstrated to be regulated by ubiquitin-mediated degradation
(30). Although these studies ruled out a role for the ubiquitin/
proteasome pathway in the regulation of Pax7, a role for CK2 has
never previously been examined. Here, we provide, to our knowl-
edge, the first evidence that CK2 mediates Pax7 stability during
muscle differentiation and is important for SC self-renewal. This
mechanism may also have implications in the regulation of the
Pax7-FOXO1 fusion protein, the overexpression of which plays a
causative role in the tumorigenicity of the skeletal muscle cancer,
alveolar rhabdomyosarcoma (31). Indeed, CK2 phosphorylation of
Pax3-FOXO1 enhances its protein stability in transformed cells
(32). This study did not address the mechanism of Pax3 degrada-
tion; however, we predict a similar mechanism involving caspase 3,
as we have demonstrated here for Pax7.
In summary, our study is, to our knowledge, the first to demon-
strate that caspase 3 limits self-renewal of a lineage restricted stem/
progenitor cell. Caspase 3 has been previously reported to inhibit
ES cell self-renewal through targeted cleavage of the pluripotency
factor Nanog (13). Therefore, it is reasonable to conclude that a
similar dichotomous phosphorylation/cleavage modification of
Nanog controls ES cell self-renewal, with CK2 and caspase 3 acting
as the respective competing enzymes. We speculate that the cas-
pase 3/CK2 targeting of self-renewal factors is a broadly conserved
phenomenon, affecting cell fate determination across all lineages.
Materials and Methods
For a more detailed discussion of the materials and methods, see SI Materials
and Methods. All animal studies were approved by the University of Ottawa
Animal Care Committee.
Fibers were isolated from 6- to 8-wk-old mice and cultured in DMEM Fiber
Media with z.DEVD.fmk (20 μM; BioVision), TBBt (20 μM; Chemicon), PAC-1 (25–
50 μM; Abcam), or DMSO (control). Inhibition of caspase 3 in vivo was accom-
plished by infecting TA muscles with adenovirus containing a p35-IRES-GFP
cassette (or IRES-GFP control) at 1 or 2 d post-CTX injury, and tissue was col-
lected at 3 and 7 d for Western blot analysis or fixed at 14 d for sectioning and
immunostaining. For in vitro cleavage assays, recombinant Pax7 protein (100–
300 ng) and recombinant active-caspase 3 (0.5 μg; Chemicon) were incubated at
37 °C for 3 h in cleavage assay buffer containing either DMSO or z.DEVD.fmk
(20 μM; BioVision) as indicated. Kinase assays were performed by combining
recombinant Pax7 (100 ng) with increasing concentrations of purified GST-CK2
in standard kinase assay conditions containing ɣ[32P]ATP (0.04 μCi/μL) for 1 h at
30 °C. Reactions were stopped by addition of Laemmli sample buffer, subjected
to SDS/PAGE, and either Western blot analysis using αPax7 primary antibody or
autoradiography. All data are expressed as means ± SEM. The Student t test
was used for comparisons between treatments unless specified, with P < 0.05
considered significant.
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